AND π Andlauer Healthcare Gr - Overview
Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA0342231077
AND: Pharmaceuticals, Vaccines, Biologics, Medical Devices, Cosmetics
Andlauer Healthcare Group Inc., a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics. It provides logistics and distribution services, including client and customer integration, transportation and inventory management, distribution and fulfillment, and warehousing solutions; and packaging services, such as co-packing and re-packing, assembly, and custom work services, as well as design, supply, and secondary Rx packaging services. The company also offers temperature-controlled services; air freight forwarding services; dedicated and last mile delivery services; and ground transportation services, including less-than-truckload, pick-up and delivery, and courier services, as well as carrier options. It provides services to healthcare manufacturers, wholesalers, distributors, 3PL providers, and others through a platform of technology-enabled supply chain solutions for a range of products, including pharmaceuticals, vaccines, biologics, blood products, narcotics, precursors, active pharmaceutical ingredients, over-the-counter, cosmetics, health and beauty aids, and medical devices, as well as natural, animal, and consumer health. The company was founded in 1991 and is headquartered in Vaughan, Canada. Andlauer Healthcare Group Inc. operates as a subsidiary of Andlauer Management Group Inc. Web URL: https://andlauerhealthcare.com
Additional Sources for AND Stock
AND Stock Overview
Market Cap in USD | 1,186m |
Sector | Industrials |
Industry | Integrated Freight & Logistics |
GiC Sub-Industry | Air Freight & Logistics |
IPO / Inception |
AND Stock Ratings
Growth 5y | 49.7% |
Fundamental | 67.9% |
Dividend | 61.9% |
Rel. Strength Industry | 248 |
Analysts | - |
Fair Price Momentum | 41.64 CAD |
Fair Price DCF | 140.79 CAD |
AND Dividends
Dividend Yield 12m | 0.92% |
Yield on Cost 5y | 2.11% |
Annual Growth 5y | 12.67% |
Payout Consistency | 98.0% |
AND Growth Ratios
Growth Correlation 3m | 82.3% |
Growth Correlation 12m | 11.9% |
Growth Correlation 5y | 32% |
CAGR 5y | 17.97% |
CAGR/Mean DD 5y | 1.13 |
Sharpe Ratio 12m | 0.36 |
Alpha | -8.71 |
Beta | 0.69 |
Volatility | 22.06% |
Current Volume | 32.2k |
Average Volume 20d | 31k |
What is the price of AND stocks?
As of December 22, 2024, the stock is trading at CAD 43.25 with a total of 32,217 shares traded.
Over the past week, the price has changed by +0.81%, over one month by +2.80%, over three months by +13.75% and over the past year by +10.10%.
As of December 22, 2024, the stock is trading at CAD 43.25 with a total of 32,217 shares traded.
Over the past week, the price has changed by +0.81%, over one month by +2.80%, over three months by +13.75% and over the past year by +10.10%.
Is Andlauer Healthcare Gr a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Andlauer Healthcare Gr (TO:AND) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 67.91 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AND as of December 2024 is 41.64. This means that AND is currently overvalued and has a potential downside of -3.72%.
Yes, based on ValueRay Fundamental Analyses, Andlauer Healthcare Gr (TO:AND) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 67.91 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AND as of December 2024 is 41.64. This means that AND is currently overvalued and has a potential downside of -3.72%.
Is AND a buy, sell or hold?
Andlauer Healthcare Gr has no consensus analysts rating.
Andlauer Healthcare Gr has no consensus analysts rating.
What are the forecast for AND stock price target?
According to ValueRays Forecast Model, AND Andlauer Healthcare Gr will be worth about 45.7 in December 2025. The stock is currently trading at 43.25. This means that the stock has a potential upside of +5.73%.
According to ValueRays Forecast Model, AND Andlauer Healthcare Gr will be worth about 45.7 in December 2025. The stock is currently trading at 43.25. This means that the stock has a potential upside of +5.73%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 47.5 | 9.8% |
Analysts Target Price | - | - |
ValueRay Target Price | 45.7 | 5.7% |